BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31654879)

  • 1. Optimization of biaryloxazolidinone as promising antibacterial agents against antibiotic-susceptible and antibiotic-resistant gram-positive bacteria.
    Wu Y; Ding X; Yang Y; Li Y; Qi Y; Hu F; Qin M; Liu Y; Sun L; Zhao Y
    Eur J Med Chem; 2020 Jan; 185():111781. PubMed ID: 31654879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of biaryloxazolidinone derivatives containing a rhodanine or thiohydantoin moiety as novel antibacterial agents against Gram-positive bacteria.
    Wu Y; Ding X; Xu S; Yang Y; Zhang X; Wang C; Lei H; Zhao Y
    Bioorg Med Chem Lett; 2019 Feb; 29(3):496-502. PubMed ID: 30553735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity evaluation of novel biaryloxazolidinone analogues containing a hydrazone moiety as promising antibacterial agents.
    Wu Y; Ding X; Ding L; Zhang Y; Cui L; Sun L; Li W; Wang D; Zhao Y
    Eur J Med Chem; 2018 Oct; 158():247-258. PubMed ID: 30218910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biaryloxazolidinone derivatives with broad-spectrum antibacterial activity, favorable drug-like profiles and in vivo efficacy against linezolid-resistant Staphylococcusaureus.
    Duan M; Qiu C; Huang X; Sun L; He X; Wang Z; Yue H; Wang K; Qi Y; Peng S; Shi X; Xi Z; Tong M; Ding X; Hou Y; Zhao Y
    Eur J Med Chem; 2024 Jul; 273():116493. PubMed ID: 38761790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of biaryloxazolidinone derivatives containing amide or acrylamide moiety as novel antibacterial agents against Gram-positive bacteria.
    Xu S; Jiang J; Qi Y; Ding X; Wu Y; Lei H; Zhao Y
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126747. PubMed ID: 31668973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility.
    Reck F; Zhou F; Eyermann CJ; Kern G; Carcanague D; Ioannidis G; Illingworth R; Poon G; Gravestock MB
    J Med Chem; 2007 Oct; 50(20):4868-81. PubMed ID: 17722903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
    Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel benzoxazinyl-oxazolidinones as potential antibacterial agents.
    Guo B; Fan H; Xin Q; Chu W; Wang H; Yang Y
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3697-9. PubMed ID: 23721807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazole) methyl oxazolidinones.
    Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
    Eur J Med Chem; 2009 Aug; 44(8):3217-27. PubMed ID: 19376613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
    J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
    Bai PY; Qin SS; Chu WC; Yang Y; Cui DY; Hua YG; Yang QQ; Zhang E
    Eur J Med Chem; 2018 Jul; 155():925-945. PubMed ID: 29966917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antibacterial cadiolide analogues active against antibiotic-resistant strains.
    Bekri S; Desriac F; Barreau M; Clamens T; Gallavardin T; Nahenec-Martel PL; Vieillard J; Datoussaid Y; Choukchou-Braham N; Lesouhaitier O; Franck X; Leleu S
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127580. PubMed ID: 32987133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
    Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
    Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
    Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
    Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria.
    Grare M; Mourer M; Fontanay S; Regnouf-de-Vains JB; Finance C; Duval RE
    J Antimicrob Chemother; 2007 Sep; 60(3):575-81. PubMed ID: 17626025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A.
    Reck F; Zhou F; Girardot M; Kern G; Eyermann CJ; Hales NJ; Ramsay RR; Gravestock MB
    J Med Chem; 2005 Jan; 48(2):499-506. PubMed ID: 15658863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
    Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
    J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies.
    Masci D; Hind C; Islam MK; Toscani A; Clifford M; Coluccia A; Conforti I; Touitou M; Memdouh S; Wei X; La Regina G; Silvestri R; Sutton JM; Castagnolo D
    Eur J Med Chem; 2019 Sep; 178():500-514. PubMed ID: 31202995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
    Phillips OA; D'Silva R; Bahta TO; Sharaf LH; Udo EE; Benov L; Eric Walters D
    Eur J Med Chem; 2015 Dec; 106():120-31. PubMed ID: 26536532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.